MSD to push for approval of HIV combo after Phase III success
|
Merck & Co (MSD) is looking to file for approval of
its human immunodeficiency virus (HIV) treatment after two positive
Phase III trial readouts. |
ANAC Series Addresses HIV Risk and Barriers in Transgender Health Care
“ HIV testing as a whole in the United States will be severely—and I mean severely with all capital letters—cut, and the people that will suffer the ... View article...